help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 2, 2009
Molecular Endocrinology, doi:10.1210/me.2009-0233
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Barclay, J. L.
Right arrow Articles by Waters, M. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barclay, J. L.
Right arrow Articles by Waters, M. J.

Submitted on June 11, 2009
Accepted on September 11, 2009

In Vivo Targeting of the Growth Hormone Receptor (GHR) Box1 Sequence Demonstrates that the GHR Does Not Signal Exclusively through JAK2

Johanna L. Barclay*, Linda M. Kerr, Leela Arthur, Jennifer E. Rowland, Caroline N. Nelson, Mayumi Ishikawa, Elisabetta M. d'Aniello, Mary White, Peter G. Noakes, and Michael J. Waters

Institute for Molecular Bioscience (J.L.B., L.M.K., L.A., C.N.N., E.M.d.A., M.J.W.) and School of Biomedical Sciences (J.E.R., M.W., P.G.N.), University of Queensland, St. Lucia, Australia 4072; Instituto Gulbenkian de Ciencia (J.E.R.), 2780 Oeiras, Portugal; and Department of Internal Medicine (M.I.), Toho University School of Medicine, Tokyo 143-8540, Japan

* To whom correspondence should be addressed. E-mail: j.barclay{at}uq.edu.au.

GH is generally believed to signal exclusively through Janus tyrosine kinases (JAK), particularly JAK2, leading to activation of signal transducers and activators of transcription (STAT), ERK and phosphatidylinositol 3-kinase pathways, resulting in transcriptional regulation of target genes. Here we report the creation of targeted knock-in mice wherein the Box1 motif required for JAK2 activation by the GH receptor (GHR) has been disabled by four Pro/Ala mutations. These mice are unable to activate hepatic JAK2, STAT3, STAT5, or Akt in response to GH injection but can activate Src and ERK1/2. Their phenotype is identical to that of the GHR- mouse, emphasizing the key role of JAK2 in postnatal growth and the minimization of obesity in older males. In particular, they show dysregulation of the IGF-I/IGF-binding protein axis at transcript and protein levels and decreased bone length. Because no gross phenotypic differences were evident between GHR- and Box1 mutants, we undertook transcript profiling in liver from 4-month-old males. We compared their transcript profiles with our 391-GHR truncated mice, which activate JAK2, ERK1/2, and STAT3 in response to GH but not STAT5a/b. This has allowed us for the first time to identify in vivo Src/ERK-regulated transcripts, JAK2-regulated transcripts, and those regulated by the distal part of the GHR, particularly by STAT5.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society